Risk Factors for Benign Breast Disease

NCT ID: NCT04127422

Last Updated: 2020-11-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

500 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-11-28

Study Completion Date

2021-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Benign diseases of the breast are common clinical conditions that affect young women. Complaints related to the breast often cause significant discomfort and mental stress. The following study will try to identify the risk factors that may be associated with symptomatic benign breast diseases. Identification of such factors may help preventing and / or treating these conditions.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Benign breast disease (BBD) is a common cause of hospital visit. In young adults, benign breast conditions surpass cancer as a cause of symptoms related to the breast. However, breast symptoms may be associated with significant distress and may impose diagnostic difficulties. Moreover, certain pathological entities of benign breast conditions are well known to increase the risk of breast cancer.

Identification of modifiable risk factors associated with symptomatic breast disorders has several potential benefits. Modification of such factors may help decrease patients' distress, hospital visits and indirectly decrease the risk of cancer.

the available data point to the possible association of several environmental factors with symptomatic BBD. Most of the available information points to an association of BBD with anthropometric features, growth pattern, family history of breast conditions and dietary consumption. Substantial evidence are however lacking and further studies are strongly required to better characterize the risk factors of the condition.

In this study, the investigators will systematically collect epidemiological, developmental and clinical data in young patients presenting with breast complaints. The association with disease incidence, pattern and histology will be examined.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Benign Breast Disease

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Benign breast disease Fibrocystic disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Study group

Patients presenting with current symptoms related to the breast. Adult females aged 18-39 years presenting to the breast outpatient clinic with either mastalgia, nodularity and/or discharge.

A questionnaire, physical examination and bilateral breast ultrasonography will be obtained for all patients.

A- The questionnaire will contain the following items:

1. symptoms related to the breast.
2. other medical history.
3. menstrual history.
4. obstetric history.
5. rapid screener for beverages and fast food consumption.
6. rapid screener for vegetables and fruit consumption.

B- Physical examination will specifically records the following:

1. breast tender point(s).
2. breast nodularity.
3. nipple discharge.
4. weight, height, body mass index (BMI).

C- bilateral breast ultrasonography for all patients.

D- breast biopsy when clinically indicated as per hospital policy.

No interventions assigned to this group

Control group

Age-matched healthy volunteers with no current medical conditions. Adult females aged 18-39 years with no current breast problems. These healthy volunteers will be asked to complete the same questionnaire as per the Study group and have anthropometric measure.

A- The questionnaire will contain the following items:

1. other medical history.
2. menstrual history.
3. obstetric history.
4. rapid screener for beverages and fast food consumption.
5. rapid screener for vegetables and fruit consumption.

B- Physical examination will specifically records the following:

1- weight, height, body mass index (BMI).

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* adult females with current symptoms related to the breast.

Exclusion Criteria

* Current or past malignancy of the breast.
* Discrete breast mass that necessitate work-up to exclude cancer.
* Current psychiatric morbidity.
* Persons unwilling to participate.
Minimum Eligible Age

18 Years

Maximum Eligible Age

39 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Mansoura University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Osama Hussein

Professor of Surgery

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Mansoura University Cancer center

Al Mansurah, , Egypt

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Osama Hussein

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

R.19.08.579

Identifier Type: -

Identifier Source: org_study_id